Kratom in the Crosshairs of Congress

Kratom’s legal future hangs in the balance as lawmakers clash over how to handle the plant-based supplement—widely used for pain and mental health but flagged by federal officials as addictive and dangerous, like opioids. A House bill passed with safeguards: age limits, clear labeling, and bans on misleading packaging. Meanwhile, a Senate bill seeks a complete ban. The FDA hasn’t classified it as a controlled substance, leaving it on store shelves nationwide. With reports of heart issues, seizures, and addiction, the debate intensifies as both bills head to different chambers—regulation vs. prohibition. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8f1df961c2a85a12